Hearing Health Newsletter: June 2026

Image: Hearing Restoration Project scientists identified gene "switches" (enhancers) that activate exclusively in the ear’s supporting cells. This marks an essential first step toward targeted gene therapies for human hearing loss. Credit: Seist et al./Hearing Research

By now the world has learned that a rare, genetic cause of hearing loss can be successfully reversed by gene therapy. With this breakthrough, gene therapy for hearing loss has transitioned from a theoretical concept into a transformative clinical reality that hopefully will extend beyond reversing a single gene variant. Hearing Health Foundation is proud to have funded many of the scientists involved, early in their careers, and our researchers continue to make inroads in this area.

Plus:


Your legacy gift supports the top-tier scientists in Hearing Health Foundation’s research programs, the Hearing Restoration Project and Emerging Research Grants. Right now your planned gift to HHF—such as a bequest or beneficiary designation of a retirement fund or life insurance policy—will be matched with our $1 million match challenge.


Around the Web:

Products and services are not endorsed by Hearing Health Foundation. Links provided are for informational purposes only, may require registration or subscription, and may expire.


Get this monthly newsletter in your inbox:  SIGN UP

Print Friendly and PDF